Safety and tolerability of combination antiretroviral post-exposure prophylaxis in a population-based setting.
Braitstein
Paula
P
Chan
Keith
K
Beardsell
Ann
A
McLeod
Alistair
A
Montaner
Julio S G
JS
O'Shaughnessy
Michael V
MV
Hogg
Robert S
RS
D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018890:Chemoprevention; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D019259:Lamivudine / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D019888:Nelfinavir / Q000009:adverse effects* / Q000627:therapeutic use; D016273:Occupational Exposure; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D018119:Stavudine / Q000009:adverse effects* / Q000627:therapeutic use; D011795:Surveys and Questionnaires
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D018119:Stavudine; D019888:Nelfinavir